- Report
- May 2022
- 38 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 42 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 35 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 44 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 45 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 35 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 35 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 101 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 57 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- May 2022
- 52 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- April 2022
- 50 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- February 2022
- 80 Pages
Africa
From €1895EUR$2,000USD£1,599GBP
- Report
- February 2022
- 40 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
Germany
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1421EUR$1,500USD£1,200GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more